Pharma and biotech companies: Don’t just merge, innovate

By Patrick Skerrett @PJSkerrett

April 20, 2016

APStock

Editor’s note: This article was mistakenly published. It has been removed from the website.

About the Author

Patrick Skerrett

Editor, First Opinion

Patrick Skerrett edits First Opinion, STAT's perspective and opinion section.

patrick.skerrett@statnews.com

Tags

pharmaceutical industry

Leave a Comment Cancel reply

Recommended

Has your insurer denied a medical claim? Stand up…

Has your insurer denied a medical claim? Stand up for your rights

Dark side of the speaker

Connecting with patients can keep physicians from becoming ‘uncomfortably…

Connecting with patients can keep physicians from becoming ‘uncomfortably numb’

Stark medication bottle

John Arnold: Trump administration’s good effort on drug rebates…

John Arnold: Trump administration’s good effort on drug rebates is bad policy

Recommended Stories

Medical bill

First Opinion

Has your insurer denied a medical claim? Stand up for your rights

By Liz Helms

Suboxone

First Opinion

Deregulating buprenorphine prescribing for opioid use disorder will save lives

By Kevin Fiscella and Sarah E. Wakeman

advertisement

Dark side of the speaker

First Opinion

Connecting with patients can keep physicians from becoming ‘uncomfortably numb’

By Benjamin Schwartz

Stark medication bottle

First Opinion

John Arnold: Trump administration’s good effort on drug rebates is bad policy

By John Arnold

Norman E. Sharpless

First Opinion

Two words to help Ned Sharpless revolutionize clinical trials: data standards

By Sam Volchenboum